Clinical Trial Update: Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction

View source ↗

Summary

Retrospective study update evaluating the use of AlloMend Acellular Dermal Matrix (ADM) allograft in pre-pectoral breast reconstruction following mastectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AlloMend Acellular Dermal Matrix (ADM) Allograft

Snippet

Sponsor: AlloSource | Conditions: Pre-Pectoral Breast Reconstruction Following Mastectomy | Status: ACTIVE_NOT_RECRUITING